Vanguard Portfolio Management
TERN

Vanguard Portfolio Management’s Terns Pharmaceuticals TERN Stock Holding History

Vanguard Portfolio Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-722,389
Closed -$38.1M – 3247
2026
Q1 		$38.1M Buy
+722,389
New +$29.7M ﹤0.01% 1736

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Portfolio Management's TERN Position: Q2 2026 in Review

Vanguard Portfolio Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 722,389 shares — an estimated $38.1M sold.

Vanguard Portfolio Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $38.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Vanguard Portfolio Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vanguard Portfolio Management sold 722,389 Terns Pharmaceuticals shares in Q2 2026, an estimated $38.1M.
  • Vanguard Portfolio Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vanguard Portfolio Management's Terns Pharmaceuticals position peaked at $38.1M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.